Beneficial Effects of a Neurotrophic Peptidergic Mixture Persist for a Prolonged Period Following Treatment Interruption in a Transgenic Model of Alzheimer's Disease

Journal of Neuroscience Research - United States
doi 10.1002/jnr.22712
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Retinal Macroglia Changes in a Triple Transgenic Mouse Model of Alzheimer's Disease

Experimental Eye Research
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2014English

Chronic Nicotine Administration Exacerbates Tau Pathology in a Transgenic Model of Alzheimer's Disease

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Neural Stem Cell Transplantation Decreases Neuroinflammation in a Transgenic Mouse Model of Alzheimer's Disease

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2015English

A Cholesterol-Lowering Drug Reduces Β-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease

Neurobiology of Disease
Neurology
2001English

Experimental Diabetes Mellitus Exacerbates Tau Pathology in a Transgenic Mouse Model of Alzheimer's Disease

PLoS ONE
Multidisciplinary
2009English

Humulus Japonicus Inhibits the Progression of Alzheimer's Disease in a APP/PS1 Transgenic Mouse Model

International Journal of Molecular Medicine
MedicineGenetics
2016English

Adiponectin Receptors Are Less Sensitive to Stress in a Transgenic Mouse Model of Alzheimer's Disease

Frontiers in Neuroscience
Neuroscience
2017English

Modulation of Γ-Secretase Reduces Β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease

Neuron
Neuroscience
2010English

Fyn Kinase Induces Synaptic and Cognitive Impairments in a Transgenic Mouse Model of Alzheimer's Disease

Journal of Neuroscience
Neuroscience
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy